01 / TRADING
Trading happens
Trades take place in the CANCER/ETH and CANCER/MRNA pools. Market activity determines each pool’s price.
A Solana project
Every trade
can matter.
CANCER is designed to turn fees from its own liquidity into MRNA token rewards, CANCER buybacks and treatment support for people living with cancer.
Pre-launch concept. Contract addresses and verified transactions will appear here when available.
2 liquidity poolsCANCER / ETH and CANCER / MRNA
3 clear destinationsRewards · burns · treatment support
0% team allocationNo team share of net LP fees
The mechanism
Two pools. One revenue model.
CANCER is planned to trade against both ETH and MRNA. Distributions come from net fees actually collected by the project’s own liquidity positions, not from total market volume.
02 / COLLECTION
Fees are collected
Only fees earned by project-owned liquidity positions are collected. Fees earned by other liquidity providers are excluded.
03 / ALLOCATION
Three destinations
Net fees are allocated: 50% to MRNA rewards, 25% to CANCER buybacks and burns, and 25% to treatment support. Each action will be documented.
Fee allocation
A purpose for
every fee.
These percentages apply only to net fees collected from project-owned liquidity. Rewards are variable and depend on actual fee income.
50 / 25 / 25Planned use of net LP fees
MRNA rewards
This share is intended to acquire MRNA Stock Tokens for distribution to eligible CANCER holders in proportion to their period-based entitlement.
CANCER buybacks & burns
This share is intended to buy CANCER on the open market and send it to a burn address. Completed transactions will be linked.
Treatment support
Reserved for cancer treatment support, delivered directly or through an organization, foundation or other legal entity.
The mission
Real support.
Visible records.
The treatment allocation must be traceable. We distinguish funds set aside from payments actually made, with supporting records where they can be shared.
Allocated first
25% of net LP fees is reserved for treatment support.
Delivered next
Actual payments to an eligible patient, institution or foundation are recorded with dates and amounts.
Privacy matters
Patient identities and health details are shared only with explicit consent.
Transparency
Let the records speak.
Live contracts and verified transaction history are not published yet. Reward, burn and support records will be linked here after launch.
CANCER / transaction and impact recordsPre-launch
MRNA reward vault
MRNA acquired from collected fees and holder entitlement records.
No data yetBuybacks and burns
Onchain links to completed buybacks and burns.
No data yetTreatment payments
Separate records of reserved funds and payments actually delivered.
No data yetContract addresses, pool links and a reward claim interface will be added after the distribution mechanism is verified and made available.
FAQ
Straight answers.
Where will MRNA rewards come from?
50% of net fees collected from the project’s own CANCER/ETH and CANCER/MRNA liquidity positions are intended for MRNA token rewards. Opening a pool alone does not create rewards.
Does holding CANCER make me a Moderna shareholder?
No. CANCER is not Moderna stock. The planned MRNA reward is not a dividend paid by Moderna; it is a token distribution funded by this project’s own fees.
Are rewards fixed?
No. LP fee income, conversion prices and eligible balances can change. Distribution contracts and entitlement rules will be published before launch.
Who will receive treatment support?
Support may be delivered directly to eligible patients or through institutions, foundations and legal entities. Completed payments will be documented while protecting personal privacy.